|
Sex (male vs. female)
|
0.72 (0.31–1.67)
|
0.445
|
|
Age (≤ 65 vs. > 65)
|
1.51 (0.79–2.91)
|
0.214
|
|
Diversion type (conduit vs. cutaneous ureterostomy)
|
2.09 (1.01–4.31)
|
0.047
|
|
Diversion type (neobladder vs. cutaneous ureterostomy)
|
2.47 (1.01–6.05)
|
0.048
|
|
Pathological T-stage (MIBC vs. NMIBC)
|
1.10 (0.58–2.07)
|
0.780
|
|
Pathological N-stage (N + vs. N−)
|
1.68 (0.58–4.85)
|
0.339
|
|
Smoking history (yes vs. no)
|
1.36 (0.72–2.59)
|
0.345
|
|
Neoadjuvant chemotherapy (yes vs. no)
|
1.48 (0.60–3.67)
|
0.397
|
|
Surgical experience (continuous)
|
1.05 (1.03–1.07)
|
< 0.001
|
